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INTRODUCTION
The neuronal migration disorders, X-linked lissencephaly
syndrome (XLIS) and subcortical band heterotopia (SBH),
also called ‘‘double cortex’’, have been linked to missense,
nonsense, aberrant splicing, deletion, and insertion mutations
in doublecortin (DCX) in families and sporadic cases (1-8).
Most DCX mutations identified to date are located in two
evolutionarily conserved domains (7, 9). The prevalence of
DCX mutations is 38-85% in sporadic SBH patients and
100% in all multiplex families with XLIS/SBH (7, 10). Be-
cause SBH is typically seen in women with heterozygous DCX
mutations and is a less severe phenotype than lissencephaly,
which is a typical phenotype of men with hemizygous muta-
tions, SBH is considered a mosaic phenotype that involves
lyonization (5). These findings suggest that the conserved
domains in DCX play a major role in neuronal migration
during neural system development. The precise explanation
for the function of the DCX protein in neuronal migration,
however, remains unknown.
We performed mutation analysis of DCX in two Korean
patients with SBH and report a novel mutation of DCX that
is responsible for SBH.
MATERIALS AND METHODS
Patients
Two unrelated Korean patients with epilepsy and SBH
(Patients 1 and 2) and their clinically unaffected family mem-
bers were studied after obtaining informed consent. The clini-
cal characteristics of the patients are summarized in Table 1.
The SBH patients had mild to moderate developmental delays,
drug-resistant generalized seizures, and diffuse thin (Fig. 1A)
and thick SBH upon brain MRI (Fig. 1B).
Mutation analysis 
DNA was extracted from peripheral blood using a stan-
dard protocol, and all coding regions of DCX (exons 1 to 7;
exon numbering according to RefSeq AJ003112.1, Gen-
Bank) were amplified by PCR. PCR assays were performed
by using 1.25 U of AmpliTaq polymerase Gold (Applied
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A Novel Missense Mutation of Doublecortin: Mutation Analysis of
Korean Patients with Subcortical Band Heterotopia
The neuronal migration disorders, X-linked lissencephaly syndrome (XLIS) and
subcortical band heterotopia (SBH), also called ‘‘double cortex’’, have been linked
to missense, nonsense, aberrant splicing, deletion, and insertion mutations in double-
cortin (DCX) in families and sporadic cases. Most DCX mutations identified to date
are located in two evolutionarily conserved domains. We performed mutation anal-
ysis of DCX in two Korean patients with SBH. The SBH patients had mild to mod-
erate developmental delays, drug-resistant generalized seizures, and diffuse thick
SBH upon brain MRI. Sequence analysis of the DCX coding region in Patient 1
revealed a c.386 C>T change in exon 3. The sequence variation results in a serine
to leucine amino acid change at position 129 (S129L), which has not been found in
other family members of Patient 1 or in a large panel of 120 control X-chromosomes.
We report here a novel c.386 C>T mutation of DCX that is responsible for SBH. 
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Biosystem, Foster City, CA, U.S.A.), 100 ng genomic DNA,
2.0 mM MgCl2, and a final concentration of 10  M for each
set of primers (Table 2). Amplification conditions were as
follows: an initial denaturing cycle at 95℃for 7 min followed
by 35 cycles of denaturation at 94℃ for 30 sec, annealing
at 62℃ for 30 sec, and extension at 72℃ for 1 min. A final
extension step of 72℃for 7 min was used. The PCR products
were electrophoresed in a 1.2% agarose gel, and the ampli-
fied genomic DNA fragments were extracted and purified
using the manufacturer’s recommended protocol (QIAquick
�
gel extraction kit; Qiagen, Germany). Direct sequencing of
both strands was performed with BigDye terminator chemistry
(PE Biosystems, Foster City, CA, U.S.A.). As the mutation
found in Patient 1 destroys an Mnl1 restriction site, restric-
tion fragment length polymorphism (RFLP) analysis was per-
formed using Mnl1 enzyme (New England BioLabs, Bever-
ly, MA, U.S.A.) for the PCR products from both the family
members of Patient 1 and 60 unaffected, unrelated Korean
women. Samples were then electrophoresed in 4% agarose.
RESULTS
Sequence analysis of the DCX coding region for Patient 1
revealed a c.386C>T change in exon 3 (Fig. 2A). The sequence
variation results in a serine to leucine amino acid change at
position 129 (S129L), which has not been found in other
family members of Patient 1, including maternal grandmother,
parents, or siblings. RFLP analysis was conducted to confirm
the sequencing result and to exclude the possibility that the
genetic variation is a polymorphism. The heterozygous mutant
band pattern was observed in Patient 1, whereas it was not
found in other family members of Patient 1 or in a control
population of 60 healthy, unrelated Korean women (Fig. 2B).
No genetic variation in DCX coding region was found for
Patient 2 and her mother. 
Pati-
ent
Age
(yr)
Sex Seizure 
onset (yr)
Neurologic features
1 26 Woman 4 Drug resistant generalized seizure,
moderate mental retardation,
ataxic gait, dysarthria, dysmetria,
mutistic, and short stature
2 14 Woman 8 Drug resistant generalized seizure,
mild to moderate mental retardation,
no neurologic deficit at age of 8 yr
Table 1. Clinical features of the patients with subcortical band
heterotopia
Fig. 1. Brain MRI scans of Patient 1 (A) and 2 (B) showing diffuse thin and thick subcortical band heterotopia, respectively.
A B
Frag-
ments
Primer 
name
Primer sequence
E1 DCX-E1F 5′ ACC GGG GGA AGA CAG AGC TAG TAA C 3′
DCX-E1R 5′ GGG GGT TGG GAG TAA GAG ATA GAG A 3′
E2 DCX-E2F 5′ TCT TTT CAC AAG CAG CAG ATT GCA G 3′
DCX-E2R 5′ CAA CCG AAG AAT GTA ACC ATA ACC A 3′
E3 DCX-E3F 5′ CCA GTG TCA GTG TGT ATT AGT TTG GTT 3′
DCX-E3R 5′ AAG AGT CCG TCA ACA AGA AAT GAT ATT 3′
E4 DCX-E4F 5′ TCA CTA GGG GTC ATG ATT CAG ACT ATG 3′
DCX-E4R 5′ ACA GGA GAA AGA CCA ACA TTA TAA GCC 3′
E5 DCX-E5F 5′ AGG TGG CTT TTG AAG GTT TCC CTA ATG 3′
DCX-E5R 5′ TTT GAC TGT TTT AGT CCC TGA ATT GAT 3′
E6 DCX-E6F 5′ TAA CTT GCT CCT TTG TAT GCT GTT GAT 3′
DCX-E6R 5′ TTG GAT TCG CAG AAC TTC AAG CTA ATG 3′
E7 DCX-E7F 5′ AAA GCA GAC ATT CCA GAG CTC AAG ATA 3′
DCX-E7R 5′ AGA TCC AGA GAA AAG GGG CAC TTG TGT 3′
Table 2. Primers used for analysis of DCX672 M.-K. Kim, M.-S. Park, B.-C. Kim, et al.
DISCUSSION
In the developing cortex, cortical neurons must migrate
long distances to reach the site of their final differentiation.
The protein encoded by the DCX gene is a cytoplasmic pro-
tein that appears to direct neuronal migration by regulating
the organization and stability of microtubules (10). Muta-
tion clusters in the DCX gene were previously identified in
exons 2 and 3, and 3 and 4, overlapping significantly with
two proposed evolutionarily conserved domains of the DCX
protein (7, 9). The first conserved domain binds tubulin and
enhances microtubule polymerization, and the second binds
tubulin less well and does not enhance microtubule assem-
bly. Both domains seem necessary for optimal DCX protein
function, and differences in the location and type of muta-
tions in these regions may produce variable functional dis-
turbances. The mutation identified in the present study is
located in the first preserved domain of the DCX protein,
which not been reported previously. 
In the setting of a family with a single girl affected with
SBH, it is hard to determine the risk for SBH or XLIS in
future children. Because of X-linkage, a male with a DCX
mutation should be clinically affected while a female with
the mutation may be unaffected due to germline or somatic
mosaicism or skewed X inactivation (5, 11-13). In the pre-
sent study, the genetic analysis of the DCX mutation c.386C>
T was negative in the maternal grandmother, mother, and
two siblings of Patient 1 who are free from SBH or XLIS.
Thus, it seems most likely that the mutation is sporadic rather
than familial. However, predicting the risk to offspring with
absolute certainty remains to be clear. 
Although Patient 2 in the present study had similar clin-
ical and radiological features to those of Patient 1, she did
not carry any genetic variation in the coding region of DCX.
This suggests that the non-coding region of DCX, including
the promoter region and introns, or other genes implicated
in neuronal migration disorders may be responsible for this
patient’s condition. Further study is required to clarify the
pathogenesis of neuronal migration disorders. 
We identified a previously unreported missense mutation
in the first preserved domain of the DCX protein. This muta-
tion S129L exhibits features suggesting that it is pathogenic.
First, like all pathogenic DCX mutations described to date,
it is heterozygous. Second, it is absent from a large panel of
120 control X-chromosomes. Third, it occurs in a highly
conserved position-the first domain of the DCX protein
where the majority of the known DCX mutations cluster.
The discovery of the new mutation reported here supports
existing evidence that mutation in the first conserved domain
of the DCX protein is important in the pathogenesis of SBH.
REFERENCES
1. Aigner L, Fluegel D, Dietrich J, Ploetz S, Winkler J. Isolated lissen-
cephaly sequence and double-cortex syndrome in a German family
with a novel doublecortin mutation. Neuropediatrics 2000; 31: 195-8.
2. des Portes V, Pinard JM, Billuart P, Vinet MC, Koulakoff A, Carrie
A, Gelot A, Dupuis E, Motte J, Berwald-Netter Y, Catala M, Kahn
A, Beldjord C, Chelly J. A novel CNS gene required for neuronal
migration and involved in X-linked subcortical laminar heterotopia
and lissencephaly syndrome. Cell 1998; 92: 51-61. 
3. Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer
I, Cooper EC, Dobyns WB, Minnerath SR, Ross ME, Walsh CA. Dou-
blecortin, a brain-specific gene mutated in human X-linked lissence-
phaly and double cortex syndrome, encodes a putative signaling pro-
tein. Cell 1998; 92: 63-72.
4. Gleeson JG, Luo RF, Grant PE, Guerrini R, Huttenlocher PR, Berg
MJ, Ricci S, Cusmai R, Wheless JW, Berkovic S, Scheffer I, Dobyns
WB, Walsh CA. Genetic and neuroradiological heterogeneity of
double cortex syndrome. Ann Neurol 2000; 47: 265-9. 
5. Gleeson JG, Minnerath S, Kuzniecky RI, Dobyns WB, Young ID,
Fig. 2. (A) Electropherogram of heterozygous c.386C>T (S129L) mutation (arrow) of DCX in Patient 1. Upper layer; normal sequence, lower
layer; mutant sequence. (B) RFLP analysis using Mnl1 enzyme shows heterozygous mutant band pattern in Patient 1 (lane 6). Lane 1 and
2; controls. Lane 3; maternal grandmother, 4; mother, 5; father, and 7, 8; siblings of Patient 1. M: DNA size marker.
A B
G    T      T     C      C     T         C      A   G      A     C      A   A
G    T      T     C      G     T         T      A   G      A     C      A   A
M1 2 3 45 6 7 8
200 bp
300
166
134 bpA Novel Missense Mutation of Doublecortin 673
Ross ME, Walsh CA. Somatic and germline mosaic mutations in
the doublecortin gene are associated with variable phenotypes. Am
J Hum Genet 2000; 67: 574-81. 
6. Kato M, Kanai M, Soma O, Takusa Y, Kimura T, Numakura C, Mat-
suki T, Nakamura S, Hayasaka K. Mutation of the doublecortin gene
in male patients with double cortex syndrome: somatic mosaicism
detected by hair root analysis. Ann Neurol 2001; 50: 547-51. 
7. Matsumoto N, Leventer RJ, Kuc JA, Mewborn SK, Dudlicek LL,
Ramocki MB, Pilz DT, Mills PL, Das S, Ross ME, Ledbetter DH,
Dobyns WB. Mutation analysis of the DCX gene and genotype/phe-
notype correlation in subcortical band heterotopia. Eur J Hum Genet
2001; 9: 5-12.
8. Pilz DT, Kuc J, Matsumoto N, Bodurtha J, Bernadi B, Tassinari CA,
Dobyns WB, Ledbetter DH. Subcortical band heterotopia in rare
affected males can be caused by missense mutations in DCX (XLIS)
or LIS1. Hum Mol Genet 1999; 8: 1757-60. 
9. Sapir T, Horesh D, Caspi M, Atlas R, Burgess HA, Wolf SG, Fran-
cis F, Chelly J, Elbaum M, Pietrokovski S, Reiner O. Doublecortin
mutations cluster in evolutionarily conserved functional domains.
Hum Mol Genet 2000; 9: 703-12.
10. Gleeson JG, Minnerath SR, Fox JW, Allen KM, Luo RF, Hong SE,
Berg MJ, Kuzniecky R, Reitnauer PJ, Borgatti R, Mira AP, Guerrini
R, Holmes GL, Rooney CM, Berkovic S, Scheffer I, Cooper EC,
Ricci S, Cusmai R, Crawford TO, Leroy R, Andermann E, Wheless
JW, Dobyns WB, Ross ME, Walsh CA. Characterization of muta-
tions in the gene doublecortin in patients with double cortex syn-
drome. Ann Neurol 1999; 45: 146-53.
11. Aigner L, Uyanik G, Couillard-Despres S, Ploetz S, Wolff G, Morris-
Rosendahl D, Martin P, Eckel U, Spranger S, Otte J, Woerle H, Hol-
thausen H, Apheshiotis N, Fluegel D, Winkler J. Somatic mosaicism
and variable penetrance in doublecortin-associated migration disor-
ders. Neurology 2003; 60: 329-32.
12. Demelas L, Serra G, Conti M, Achene A, Mastropaolo C, Matsumo-
to N, Dudlicek LL, Mills PL, Dobyns WB, Ledbetter DH, Das S.
Incomplete penetrance with normal MRI in a woman with germline
mutation of the DCX gene. Neurology 2001; 57: 327-30.
13. Poolos NP, Das S, Clark GD, Lardizabal D, Noebels JL, Wyllie E,
Dobyns WB. Males with epilepsy, complete subcortical band hetero-
topia, and somatic mosaicism for DCX. Neurology 2002; 58: 1559-62.